Phost’in Therapeutics

Phost’in Therapeutics is a biotech company in Montpellier, France. It has raised $15.7M across 2 rounds.

First-in-Class Glycocalyx Modifiers for selective cancer treatment

Headquarters
Montpellier
Employees
1–10
Business Model
B2B
Total Funding
$15.7M
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.

About

Phost'in Therapeutics is a Montpellier, France-based clinical-stage biotech company discovering and developing First-in-Class Glycocalyx Modifiers for the selective treatment of solid cancers and other serious diseases. The company's lead program targets aberrant N-glycosylation on tumor cell surfaces — a well-characterized hallmark of cancer — using novel small molecule inhibitors of carbohydrate-related enzymes such as GnT-V. Phost'in's lead candidate PhOx430 is advancing toward clinical trials in partnership with Fondazione Gianni Bonadonna, and the company secured €3.2M in non-dilutive France 2030 I-DEMO funding in 2026 to expand its pipeline.

Summary

It lists 1–10 employees. It has raised $15.7M in total across 2 rounds. Investors include Remiges Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries A
$12.0M

Sign up to see all 2 events

Funding, valuations, and company events, with amounts and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Phost’in Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/phost-in-therapeutics"><img src="https://indexed.vc/api/badge/company/phost-in-therapeutics" alt="Phost’in Therapeutics on Indexed.vc" width="260" height="76" /></a>